相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。被撤回的出版物: Silencing of Long Non-coding RNA HOTTIP Reduces Inflammation in Rheumatoid Arthritis by Demethylation of SFRP1 (Retracted article. See vol. 28, pg. 637, 2022)
Xumin Hu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Epigenetics of SFRP1: The Dual Roles in Human Cancers
Rashidah Baharudin et al.
CANCERS (2020)
Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis
Shohda A. El-Maraghy et al.
JOURNAL OF ADVANCED RESEARCH (2020)
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2020)
LncRNAs in HCV Infection and HCV-Related Liver Disease
Juan P. Unfried et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Kaku Goto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p/FOXA1/AGR2 Signaling Pathway
Zhen Yuan et al.
ONCOTARGETS AND THERAPY (2020)
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D'souza et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
Xiuzhu Gao et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)
Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
Srikanta Dash et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
Ji Liu et al.
THERANOSTICS (2020)
A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6
Xiao Liu et al.
HEPATOLOGY (2019)
Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4 alpha
Shangdong Guo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
Naoki Umezaki et al.
CANCER SCIENCE (2019)
Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis
Siwen Dang et al.
ONCOGENE (2019)
HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition
Hongjie Ji et al.
CANCER RESEARCH (2019)
Lnc-ITM2C-1 and GPR55 Are Proviral Host Factors for Hepatitis C Virus
Pan Hu et al.
VIRUSES-BASEL (2019)
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals
Shira Perez et al.
PLOS GENETICS (2019)
HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma
Baharan Fekry et al.
CANCER RESEARCH (2019)
被撤回的出版物: Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression (Retracted article. See MAR, 2023)
Jiang-Hua Dai et al.
CELL CYCLE (2019)
Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1
Dong-Wei Liu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension
Yan Xing et al.
MOLECULAR THERAPY (2019)
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
Suofeng Sun et al.
BMC MEDICAL GENOMICS (2019)
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma
Yinan Zheng et al.
CLINICAL EPIGENETICS (2019)
Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma
Sangchul Kim et al.
BIOMOLECULES (2019)
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression
Bing Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
Nathalie Alazard-Dany et al.
VIRUSES-BASEL (2019)
Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma
Yan Guo et al.
CANCER BIOLOGY & THERAPY (2018)
Insulin-Like Growth Factor (IGF) System in Liver Diseases
Agnieszka Adamek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection
Siyuan Ding et al.
NATURE COMMUNICATIONS (2018)
Regulation of the Interferon Response by lncRNAs in HCV Infection
Saba Valadkhan et al.
FRONTIERS IN MICROBIOLOGY (2018)
Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
Yoshinobu Shigekawa et al.
Oncotarget (2018)
Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma
Baharan Fekry et al.
NATURE COMMUNICATIONS (2018)
Histone Deacetylase 3 Inhibitor Suppresses Hepatitis C Virus Replication by Regulating Apo-A1 and LEAP-1 Expression
Yuan Zhou et al.
VIROLOGICA SINICA (2018)
A novel anti-viral role for STAT3 in IFN-α signalling responses
Rebecca Mahony et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets
N. A. Wijetunga et al.
ONCOGENE (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
Shujiao He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Hepatitis C Virus Lipoviroparticles Assemble in the Endoplasmic Reticulum (ER) and Bud off from the ER to the Golgi Compartment in COPII Vesicles
Gulam H. Syed et al.
JOURNAL OF VIROLOGY (2017)
Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma
Gaofeng Sun et al.
MEDICINE (2017)
A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood
A. R. Lourenco et al.
ONCOGENE (2017)
Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma
Liang Jiang et al.
Oncology Letters (2017)
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling
Naicui Zhai et al.
PLOS ONE (2017)
Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin
Dalia S. Elhelw et al.
ARCHIVES OF VIROLOGY (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes
Barbara Testoni et al.
GUT (2016)
BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma
Guozhi Yin et al.
BMC CANCER (2016)
miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)
Qiao Zhu et al.
BMC CANCER (2016)
Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV
Shereen A. El Sobky et al.
IMMUNOLOGY LETTERS (2016)
Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology
Quan Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future
Xue Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
Junro Kataoka et al.
ONCOLOGY REPORTS (2016)
DNA methyltransferase 1, 3a, and 3b expression in hepatitis C associated human hepatocellular carcinoma and their clinicopathological association
Nadir Naveed Siddiqui et al.
TUMOR BIOLOGY (2016)
PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs
Qing Shi et al.
VIROLOGY (2016)
The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
Lei Li et al.
ONCOLOGY LETTERS (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7
Jiayu Chen et al.
CANCER CELL INTERNATIONAL (2015)
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
Benedicte Delire et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Satdarshan Pal Monga
GASTROENTEROLOGY (2015)
From non-A, non-B hepatitis to hepatitis C virus cure
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2015)
Proportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patients
Ping Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma
Haohai Zhang et al.
ONCOTARGET (2015)
Hepatitis C virus NS5A drives a PTEN-PI3K/Akt feedback loop to support cell survival
Du Cheng et al.
LIVER INTERNATIONAL (2015)
Long noncoding RNAs in innate and adaptive immunity
Katherine A. Fitzgerald et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
RASSF tumor suppressor gene family: Biological functions and regulation
Natalia Volodko et al.
FEBS LETTERS (2014)
Hepatocyte Nuclear Factor 4α-Nuclear Factor-κB Feedback Circuit Modulates Liver Cancer Progression
Bei-Fang Ning et al.
HEPATOLOGY (2014)
Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma
Sumadi Lukman Anwar et al.
JOURNAL OF PATHOLOGY (2014)
Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition
H. Quan et al.
ONCOGENE (2014)
Concurrent Activation of Acetylation and Tri-Methylation of H3K27 in a Subset of Hepatocellular Carcinoma with Aggressive Behavior
Akimasa Hayashi et al.
PLOS ONE (2014)
Long non-cocing RNAs involved in immuune responses
Katsutoshi Lmamura et al.
FRONTIERS IN IMMUNOLOGY (2014)
Wnt signaling in liver fibrosis: Progress, challenges and potential directions
Cheng-gui Miao et al.
BIOCHIMIE (2013)
Non-Cell-Autonomous Tumor Suppression by p53
Amaia Lujambio et al.
CELL (2013)
Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes
Nigel J. Stevenson et al.
FEBS LETTERS (2013)
Histone Lysine Methyltransferase, Suppressor of Variegation 3-9 Homolog 1, Promotes Hepatocellular Carcinoma Progression and Is Negatively Regulated by MicroRNA-125b
Dorothy Ngo-Yin Fan et al.
HEPATOLOGY (2013)
Epigenetic Regulation of MicroRNA-122 by Peroxisome Proliferator Activated Receptor-gamma and Hepatitis B Virus X Protein in Hepatocellular Carcinoma Cells
Kyoungsub Song et al.
HEPATOLOGY (2013)
Multidomain integration in the structure of the HNF-4α nuclear receptor complex
Vikas Chandra et al.
NATURE (2013)
Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma
X. Xue et al.
ONCOGENE (2013)
Recent Advancements in Comprehensive Genetic Analyses for Human Hepatocellular Carcinoma
Naoshi Nishida et al.
ONCOLOGY (2013)
STAT1 negatively regulates hepatocellular carcinoma cell proliferation
Guofu Chen et al.
ONCOLOGY REPORTS (2013)
Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation
Joo Song Lim et al.
CANCER LETTERS (2012)
Epigenetic regulation of miR-124 by Hepatitis C Virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3
Bing Zeng et al.
FEBS LETTERS (2012)
Role of low-density lipoprotein receptor in the hepatitis C virus life cycle
Anna Albecka et al.
HEPATOLOGY (2012)
Cellular senescence and tumor suppressor gene p16
Hani Rayess et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Transient Activation of the PI3K-AKT Pathway by Hepatitis C Virus to Enhance Viral Entry
Zhe Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus
Hongyan Liu et al.
PLOS ONE (2012)
Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway
Keiichi Tamai et al.
VIROLOGY (2012)
Molecular Determinants and Dynamics of Hepatitis C Virus Secretion
Kelly E. Coller et al.
PLOS PATHOGENS (2012)
EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies
Mu-Yan Cai et al.
GUT (2011)
Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer
Diego F. Calvisi et al.
JOURNAL OF HEPATOLOGY (2011)
Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling
Shin-Ichi Nishina et al.
ONCOLOGY REPORTS (2011)
P16 gene hypermethylation and hepatocellular carcinoma: A systematic review and meta-analysis
Jia-Jie Zang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
C/EBPα Is Up-regulated in a Subset of Hepatocellular Carcinomas and Plays a Role in Cell Growth and Proliferation
Guo-Dong Lu et al.
GASTROENTEROLOGY (2010)
Hepatitis C Virus Inhibits DNA Damage Repair through Reactive Oxygen and Nitrogen Species and by Interfering with the ATM-NBS1/Mre11/Rad50 DNA Repair Pathway in Monocytes and Hepatocytes
Keigo Machida et al.
JOURNAL OF IMMUNOLOGY (2010)
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2010)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis
Morris Sherman
SEMINARS IN LIVER DISEASE (2010)
Wnt signal transduction pathways
Yuko Komiya et al.
Organogenesis (2010)
Acetylation/Deacetylation Modulates the Stability of DNA Replication Licensing Factor Cdt1
Michele A. Glozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma
Diego F. Calvisi et al.
CANCER RESEARCH (2008)
microRNA-122 stimulates translation of hepatitis C virus RNA
Jura Inga Henke et al.
EMBO JOURNAL (2008)
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
R. Schickel et al.
ONCOGENE (2008)
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus
Narayan Dharel et al.
HEPATOLOGY (2008)
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas
Yutaka Kondo et al.
HEPATOLOGY RESEARCH (2007)
Interferon modulation of cellular microRNAs as an antiviral mechanism
Irene M. Pedersen et al.
NATURE (2007)
Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers
Hongchuan Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins
Hua Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
TP53 mutations and hepatocellular carcinoma:: insights into the etiology and pathogenesis of liver cancer
S. P. Hussain et al.
ONCOGENE (2007)
Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas
J. Zucman-Rossi et al.
ONCOGENE (2007)
Hepatitis C virus entry depends on clathrin-mediated endocytosis
Emmanuelle Blanchard et al.
JOURNAL OF VIROLOGY (2006)
Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry
DM Tscherne et al.
JOURNAL OF VIROLOGY (2006)
Viral hepatitis and liver cancer: the case of hepatitis C
M. Levrero
ONCOGENE (2006)
New therapies for hepatocellular carcinoma
M. A. Avila et al.
ONCOGENE (2006)
Mechanistic link between the anti.HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade
Y Huang et al.
HEPATOLOGY (2006)
TAp73/ΔNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma
M Müller et al.
CELL DEATH AND DIFFERENTIATION (2005)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Hypermethylation of the RUNX3 gene in hepatocellular carcinoma
WS Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2005)
MicroRNAs: a developing story
AE Pasquinelli et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Hepatitis C virus expression suppresses interferon signaling by degrading STAT1
WY Lin et al.
GASTROENTEROLOGY (2005)
Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein
CF Kao et al.
ONCOGENE (2004)
Hepatitis C virus replication in stably transfected HepG2 cells promotes hepatocellular growth and tumorigenesis
BS Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis
Y Edamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-γ stimuli
A Hosui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Liver p53 expression in patients with HCV-related chronic hepatitis
C Loguercio et al.
JOURNAL OF VIRAL HEPATITIS (2003)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli et al.
EMBO JOURNAL (2002)
ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors
AI Zaika et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
HCVNS5A interacts with p53 and inhibits p53-mediated apoptosis
KH Lan et al.
ONCOGENE (2002)
G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis
M Tachibana et al.
GENES & DEVELOPMENT (2002)
分享论文
